Investing.com - Applied Genetic reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that topped expectations. Applied Genetic announced...
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Industrials, Healthcare and Financials sectors led shares lower. At the close in NYSE, the...
1. ACM Research (ACMR) Acm Research (NASDAQ:ACMR) exploded on Wednesday, jumping 5.84, or 14%, to 48.51, after reaching a session and 52-week high of 51.20, on 2.8 million shares....
1. Applied Genetic Technologies (AGTC) Applied Genetic (NASDAQ:AGTC) exploded from the Dec low when it was trading at about 2 3/4 to 5 1/2 in 4-5 days, pulled back in a nice...
Applied Genetic Technologies Corporation (NASDAQ:AGTC) announced positive interim six-month data from the phase I/II study evaluating its adeno-associated virus ("AAV")-based...
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.
|Average||8.250 (+2933.09% Upside)|
|No. of Analysts||6|